- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Cultivating Equality in the Garden State
In this fifth, and final, special bonus episode of our Pride Month series, we speak with Lauren Albrecht, director of advocacy and organizing, and Layla Orlando, director of health equity and wellness, at Garden State Equality, the largest lesbian, gay, bisexual, transgender, queer, plus advocacy organization in New Jersey.
Garden State Equality celebrates its 20th anniversary this year. Since its founding in 2004, it has grown to more than 150,000 members | Image Credit: Garden State Equality
Welcome to the final episode in our special Pride Month series. In this special edition of Managed Care Cast, we speak with Lauren Albrecht, director of advocacy and organizing, and Layla Orlando, director of health equity and wellness, at Garden State Equality, first founded in 2004 and which has grown to become the largest lesbian, gay, bisexual, transgender, queer, plus (LGBTQ+) advocacy organization in New Jersey, at more than 150,000 members.
Racial, economic, and disability justice concerns underpin this advocacy and civil rights organization’s mission to bring full equality to all members of all LGBTQ+ communities in the state. We discuss state- and federal-level legislation, with potential implications on not only LGBTQ+ rights in the state, but reproductive freedom as well; notable achievements for the LGBTQ+ community in New Jersey; and, as with our previous episodes in this limited-edition series, health care policy in this election year.
Please check out our previous episodes with Lancaster Pride, Rutgers, Callen-Lorde, and We Are Family.
Health Equity & Access Weekly Roundup: January 11, 2025
January 11th 2025ACA enrollment rate hits a milestone, though IRA subsidies may not extend beyond 2025; network adequacy standards fail to translate into efficient access to mental health care for Medicaid enrollees; research examines racial disparities in postpartum hypertension and vaccine uptake.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
